特斯卡 TRNS 深 滬
已收盤 01-09 16:00:00 美东时间
65.36
+2.120
+3.35%
華盛通- 最 高66.645
- 今 開63.24
- 成交量 11.07万股
- 最 低 62.0001
- 昨 收 63.24
- 總市值 6.10亿
- 52周最高 107.015
- 市盈率 靜 41.67
- 換手率 1.19%
- 52周最低 50.23
- 委 比 55.41%
- 總股本 932.84万
- 歷史最高 147.115
- 量 比 1.16
- 振 幅 7.34%
- 歷史最低 4.97
- 每 手 1
- 風險率 11.57%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多Edwards Lifesciences 2026 EPS guidance range includes consensus
Edwards Lifesciences (EW) newly projected 2026 adjusted EPS guidance of $2.80-$2.95 includes to consensus figure of $2.86. The maker of products to treat advanced cardiovascular diseases also sees con...
2025-12-04 23:07
Transcat Q2 Adj. EPS $0.44 Misses $0.51 Estimate, Sales $82.300M Beat $79.512M Estimate
Transcat (NASDAQ:TRNS) reported quarterly earnings of $0.44 per share which missed the analyst consensus estimate of $0.51 by 12.87 percent. This is a 15.38 percent decrease over earnings of $0.52 per share from the same
2025-11-04 04:51
Earnings Scheduled For November 3, 2025
Companies Reporting Before The Bell • CNA Financial (NYSE:CNA) is expected to r...
2025-11-03 19:11
华尔街顶级分析师最新评级报告：联合健康遭下调
华尔街最受关注、且能影响市场走势的研究评级报告现已汇总于此。以下是由 The Fly 整理的今日投资者需重点关注的评级信息。 五大评级上调案例 思佳讯...
2025-10-29 22:12
Anteris Technologies To Present One-Year Clinical Outcomes With DurAVR Transcatheter Heart Valve, At TCT 2025
Anteris Technologies Global Corp. (Anteris or the Company) (NASDAQ:AVR, ASX: AVR))), a global structural heart company committed to designing, developing, and commercializing cutting-edge medical devices to restore
2025-10-27 20:47
Three-year SPYRAL HTN-ON MED results show sustained, 18 mmHg office-based blood pressure reductions
Long-term data shows significant and sustained blood pressure reductions in both office-based and 24-hour ambulatory blood pressure, reinforcing the durability, safety and effectiveness of t...
2025-10-27 05:24
Anteris Technologies Receives Danish Regulatory Clearance To Launch Global PARADIGM Trial For DurAVR Heart Valve
Anteris Technologies Global Corp. (Anteris or the Company) (NASDAQ:AVR, ASX: AVR))) a global structural heart company committed to designing, developing, and commercializing cutting-edge medical devices to restore
2025-10-15 21:21
Transcat Announces New Corporate Controller Appointment
Transcat ( ($TRNS) ) has shared an update. Transcat, Inc. has announced the ret...
2025-09-12 04:59
Transcat CEO to step down; FY26 outlook reaffirmed
Transcat (NASDAQ:TRNS) said Monday that CEO Lee D. Rudow will step down in March 2026 after more than 10 years in the role and will remain as a strategic advisor through 2027. The company has also rea...
2025-08-26 04:21
